Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Are you a Dividend Trader
Learn how to make passive income from the best dividend stocks.
...
Health Technology » Pharmaceuticals Other
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| VRX | Valeant Pharmaceuticals International, Inc. | -1.84% | 24.27 | 14.1% | $215.51m | |
| SHPG | Shire PLC Sponsored ADR | -0.34% | 161.85 | 0.4% | $146.66m | |
| JAZZ | Jazz Pharmaceuticals Plc | -0.91% | 178.50 | 2.2% | $132.60m | |
| SAGE | SAGE Therapeutics, Inc. | -4.83% | 153.46 | 9.6% | $122.44m | |
| ENDP | Endo International Plc | 1.94% | 9.48 | 8.9% | $88.71m | |
| PRGO | Perrigo Co. Plc | 0.40% | 75.65 | 6.7% | $87.94m | |
| ICPT | Intercept Pharmaceuticals, Inc. | 1.86% | 85.67 | 21.8% | $66.06m | |
| MNK | Mallinckrodt Plc | -0.93% | 19.26 | 21.1% | $57.13m | |
| PTLA | Portola Pharmaceuticals, Inc. | 4.14% | 43.73 | 7.7% | $53.35m | |
| GWPH | GW Pharmaceuticals PLC Sponsored ADR | 0.16% | 151.25 | 7.6% | $52.62m | |
| CTLT | Catalent Inc | -0.67% | 41.54 | 2.6% | $52.58m | |
| SUPN | Supernus Pharmaceuticals, Inc. | -2.23% | 57.05 | 6.3% | $41.50m | |
| HZNP | Horizon Pharma plc | 0.23% | 17.67 | 7.5% | $38.10m | |
| UTHR | United Therapeutics Corporation | -0.22% | 116.47 | 14.4% | $36.89m | |
| AERI | Aerie Pharmaceuticals, Inc. | 4.60% | 70.45 | 7.9% | $35.61m |
Company Profile
Ironwood Pharmaceuticals, Inc. operates as commercial biotechnology company, which discovers, develops and commercializes differentiated medicines that improve patient's lives. Its products include linaclotide, a guanylate cyclase type-C agonist being developed for the treatment of patients with irritable bowel syndrome with constipation and chronic constipation; and lesinurad for the treatment of hyperuricemia associated with uncontrolled gout. The company was founded by Peter M. Hecht, Eric F. Summers, G. Todd Milne, Brian M. Cali, Joseph C. Cook, Jr. and Gina Bornino Miller on January 5, 1998 and is headquartered in Cambridge, MA.